Wang et al reported that silencing Wnt2B can decrease the capacity of metastatic dissemination for ovarian cancer cells, and the decreased Wnt2B expression can inhibit cancer cell survival and promote cell apoptosis after chemotherapy treatment.33 The gene discussed is WNT2B; the disease is ovarian cancer.